Pfizer

2026. g. 17. sept. 22:51 UTC

Pfizer Inc. is gaining modestly in after-market trading, influenced by fluctuations and the performance of Bristol-Myers Squibb's Phase 3 study results.

2026. g. 16. sept. 20:10 UTC

Pfizer Inc faces social media scrutiny over its drug pipeline needs, contributing to a decline despite exceeding revenue and earnings expectations.

2026. g. 15. sept. 23:02 UTC

Pfizer Inc. shares are roughly flat in after-market trading amid broader market sentiment affected by a decline in the New York Empire State Manufacturing Index.

2026. g. 14. sept. 23:01 UTC

Pfizer Inc shares are lower in after-market hours, with no specific news identified. Broader market declines are linked to rising crude oil prices.

2026. g. 11. sept. 23:06 UTC

Pfizer Inc shares are slightly higher in after-market hours, with no specific news identified. The broader market reacted to August's Consumer Price Index data.

2026. g. 9. sept. 20:07 UTC

Pfizer Inc. is gaining during Wednesday's session despite mixed market reactions to its trademark deal with Novartis India, which may impact earnings.

2026. g. 8. sept. 20:08 UTC

Pfizer shares are lower as the company announces a webcast featuring CEO Albert Bourla at the Morgan Stanley Healthcare Conference scheduled for September 2026.

2026. g. 4. sept. 23:05 UTC

Pfizer Inc shares are lower in after-market hours, reflecting a slight decline since Friday's close amid mixed economic signals affecting market sentiment.

2026. g. 3. sept. 23:01 UTC

Pfizer Inc. shares are lower in after-market hours, following a weak trading session and amid broader market softness from recent economic data on jobless claims.

2026. g. 2. sept. 23:06 UTC

Pfizer Inc. shares are lower in after-market hours, amid a weaker ADP payrolls report signaling potential labor market weakness affecting future Federal Reserve policy.

2026. g. 1. sept. 20:09 UTC

Pfizer Inc shares reached a 22-month high of $28.86 today, driven by a significant upward trend in the Pharmaceuticals sub-sector amid overall market gains.

2026. g. 31. aug. 23:06 UTC

Pfizer Inc shares rose in after-hours trading, holding above the 20-day moving average and near the upper end of their one-month range.

2026. g. 28. aug. 23:01 UTC

Pfizer Inc. shares are lower in after-market trading, continuing a trend from the previous three sessions. No specific news was identified to explain the decline.

2026. g. 27. aug. 23:02 UTC

Pfizer and BioNTech received FDA approval for their XFG-adapted COVID-19 vaccine, COMIRNATY XFG, boosting shares in after-market trading.

2026. g. 26. aug. 23:06 UTC

Pfizer Inc shares are lower in after-market hours amid notable volatility. Broader market weakness and a stronger U.S. Dollar Index contributed to the decline.

2026. g. 25. aug. 23:06 UTC

Pfizer Inc. shares are lower in after-market trading, reflecting weaker sentiment amid broader market declines linked to falling crude oil prices.

2026. g. 24. aug. 19:36 UTC

Pfizer Inc. shares are lower today, continuing a decline since Friday's close. The stock remains above its 20-day moving average.

2026. g. 21. aug. 23:01 UTC

Pfizer Inc shares are lower in after-market trading, reflecting a downward trend amid broader market volatility related to inflation and government debt concerns.

2026. g. 20. aug. 19:41 UTC

Pfizer Inc's shares are lower today amid a broader downturn in the Pharmaceuticals sub-sector, marking a shift from recent gains.

2026. g. 19. aug. 23:51 UTC

Pfizer Inc shares are lower in after-market hours, reversing gains from three consecutive sessions. No specific news was identified to explain the price action.

2026. g. 18. aug. 19:16 UTC

Pfizer reported second-quarter adjusted EPS of $0.77, exceeding estimates, and raised its sales outlook for fiscal year 2026, with shares trading higher.

2026. g. 17. aug. 23:36 UTC

Pfizer Inc shares are lower in after-market hours following the announcement of Xtandi's new indication for prostate cancer treatment. The broader market also declined.

2026. g. 14. aug. 23:51 UTC

Pfizer Inc. shares are higher in after-market hours amid broader economic concerns following a reported decline in U.S. retail sales for July.

2026. g. 13. aug. 23:16 UTC

Pfizer Inc shares are lower in after-market hours following a decline from earlier gains. No specific news was identified to explain the movement.

2026. g. 12. aug. 23:02 UTC

Pfizer shares rose after Chairman Albert Bourla bought 38,000 shares at $26.34, totaling about $1 million, signaling confidence in the company's prospects.

2026. g. 11. aug. 19:26 UTC

Pfizer Inc. shares are lower amid a $44 million settlement over its Chantix drug, which allegedly contained a cancer-linked substance.

2026. g. 10. aug. 23:01 UTC

Pfizer Inc. shares are lower in after-market hours, continuing a decline since Monday's close amid rising Treasury yields and inflation concerns.

2026. g. 8. aug. 00:02 UTC

Pfizer Inc shares are lower in after-market hours with no specific news identified. Broader market concerns about interest rate hikes continue to influence sentiment.

2026. g. 7. aug. 23:01 UTC

Pfizer Inc shares are lower in after-market hours, reaching a session low earlier. No specific news was identified to explain the decline.

2026. g. 6. aug. 23:51 UTC

Pfizer Inc shares are lower in after-market hours. The decline follows increased crude oil prices and a strengthening U.S. dollar, contributing to market volatility.